Interacting Drugs |
Sumatriptan and naproxen vs Ergot Derivatives |
Security Level |
![]() |
Mechanism |
Ergot Derivatives: May enhance the vasoconstricting effect of Serotonin 5-HT1D Receptor Agonists. Serotonin 5-HT1D Receptor Agonists may enhance the vasoconstricting effect of Ergot Derivatives. |
Management |
Avoid combination |
Sumatriptan and naproxen vs Ergot Derivatives
Post Review about Sumatriptan and naproxen vs Ergot Derivatives Click here to cancel reply.
Other Interactions of Sumatriptan and naproxen
Other Interactions of Ergot Derivatives
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.